Liang, Mei-Chih
Harvard University · Massachusetts General Hospital · Dana-Farber Cancer Institute · Dana-Farber/Harvard Cancer Center · Cell Signaling Technology (United States)
3 papers on CoChatORCID 0000-0002-7389-2455
Most cited papers
- Verified
LKB1 modulates lung cancer differentiation and metastasis
Ji, H., Ramsey, M. R., Hayes, D. N., Fan, C., McNamara, K., Kozlowski, P., Torrice, C., Wu, M. C., Shimamura, T., Perera, S. A., et al. (2007) · Nature
Lung Cancer Research StudiesLung Cancer Treatments and Mutations
Cited by 1,064
- Verified
Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition
Faber, A. C., Li, D., Song, Y., Liang, M.-C., Yeap, B. Y., Bronson, R. T., Lifshits, E., Chen, Z., Maira, S.-M., García-Echeverría, C., et al. (2009) · Proceedings of the National Academy of Sciences
PI3K/AKT/mTOR signaling in cancerLung Cancer Treatments and Mutations
Cited by 319
- Verified
An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation
Schoeberl, B., Faber, A. C., Li, D., Liang, M.-C., Crosby, K., Onsum, M., Burenkova, O., Pace, E., Walton, Z., Nie, L., et al. (2010) · Cancer Research
HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations
Cited by 264
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free